March 2017 Quarter Results & Investor Conference Call
Filed with ASX · · 2 pages · English
Earlier from ImpediMed
- SOZO Shipped to Vanderbilt to Commence At-Home Study
- Placement of First SOZO Unit at Scripps Health
- Appendix 4D and Financial Report 31 December 2016
- Appendix 4C - Quarter Ended 31 December 2016
- Appendix 4C - Quarter Ended 30 September 2016
Later from ImpediMed
- L-Dex Study - Significant Reduction in Clinical Lymphoedema
- Macquarie University Commences Lymphoedema Study Using Sozo
- SOZO obtains CE Mark for Heart Failure Patient Monitoring
- L-Dex Recommended in Clinical Practice Guidelines
- IPD Submits FDA 510(k) Application for SOZO for Lymphoedema
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed